October 15, 2010
– Comments (3)
It might be a good idea to sell a few MIPI shares if you have some ("profit taking").
Molecular Insight Pharmaceuticals Presents Positive Data From Clinical Studies Comparing Trofex(TM) and ProstaScint(R) for Detection of Metastatic Prostate Cancer
Congrats on the call here...